SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion

International Journal of Cancer

Volumn 122, Issue 12, 2008, Pages 2735-2743

  Yunker, Christopher K ^a   Golembieski, William ^a   Lemke, Nancy ^a   Schultz, Chad R ^a   Cazacu, Simona ^a   Brodie, Chaya ^a   Rempel, Sandra A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Collagen I; Gliomas; Matrix; SPARC; Vascularity; VEGF(R1 2)

Indexed keywords

COLLAGEN TYPE 1; OSTEONECTIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; TUMOR CELL; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; COLLAGEN TYPE I; DNA PRIMERS; GLIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; OSTEONECTIN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43049121355     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23450     Document Type: Article

References (47)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
2. Maher EA, Funari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001;15:1311-33.
3. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol 2007;8:R131.
4. Bomstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002;14:608-16.
5. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 2000;19:816-27.
6. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 1994;125:929-43.
7. Bergson C, Zhao H, Saijoh K, Duman RS, Neter EJ. Ezrin and osteonectin, two proteins associated with cell shape and growth, are enriched in the locus coeruleus. Mol Cell Neurosci 1993;4:64-73.
8. Yan Q, Sage EH, Hendrickson AE. SPARC is expressed by ganglion cells and astrocytes in bovine retina. J Histochem Cytochem 1998;46:3-10.
9. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994;8:163-73.
10. Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T, Gutierrez JA. SPARC. A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 1998;57:1112-21.
11. Golembieski WA, Ge S, Nelson K, Mikkelsen T, Rempel SA. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci 1999;17:463-72.
12. Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 2007;26:4084-94.
13. Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 2002;62:6270-77.
14. Rich JN, Shi Q, Hjelmeland M, Cummings TJ, Kuan CT, Bigner DD, Counter CM, Wang XF. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J Biol Chem 2003;278:15951-7.
15. Berens ME, Giese A. "...those left behind." Biology and oncology of invasive glioma cells. Neoplasia 1999;1:208-19.
16. Funk SE, Sage EH. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 1993;154:53-63.
17. 2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:2648-52.
18. Lopes MD. Angiogenesis in brain tumors. Microsc Res Tech 2003;60:225-30.
19. Kupprion C, Motamed K, Sage EH. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 1998;273:29635-40.
20. Herold-Mende C, Andl T, Steiner HH, Riede D, Buttler A, Reisser C, Fusenig NE, Mueller MM. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest 1999;79:1573-82.
21. Steiner H-H, Karcher S, Mueller MM, Nalbantis E, Kunze S, Herold-Mende C. Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol 2004;66:129-38.
22. Kaufman LJ, Brangwynne CP, Kasza KE, Filippidi E, Gordon VD, Deisboeck TS, Weitz DA. Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility pattems. Biophys J 2005;89:635-50.
23. Davis GE, Senger DR. Endothelial extracellular matrix. Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessels stabilization. Circ Res 2005;97:1093-107.
24. Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 1999;47:1495-1505.
25. Honma K, Miyata T, Ochiya T. Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells. Cancer Cell Int 2007;7:12-21.
26. Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer 2006;118:310-16.
27. Bangle R, Alford WC. The chemical basis of the periodic acid Schiff reaction of collagen fibers with reference to periodate consumption by collagen and by insulin. J Histochem Cytochem 1954;2:62-76.
28. Reed MJ, Bradshaw AD, Shaw M, Sadoun E, Han N, Ferara N, Funk S, Puolakkainen P, Sage EH. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age. J Cell Physiol 2005;204:800-7.
29. Brewer CA, Setterdahl JJ, Li MJ, Johnston JM, Mann JL, McAsey ME. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 2000;96:224-8.
30. Menon PM, Gutiérrez JA, Rempel SA. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC expression correlates with decreased migration on vitronectin. Int J Oncol 2000;17:683-93.
31. Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 2001;53:149-60.
32. Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest 2006;116:422-9.
33. Golembieski WA, Rempel SA. cDNA array analysis of SPARC-modulated changes in glioma gene expression. J Neurooncol 2002;60:213-26.
34. Watarai M, Miwa H, Shikami M, Sugamura K, Wakabayashi M, Satoh A, Tsuboi K, Imamura A, Mihara H, Katoh Y, Kita K, Nitta M. Expression of endothelial cell-associated molecules in AML cells. Leukemia 2002;16:112-19.
35. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action. In vivo effect on angiogenesis and endogenous protein expression. Cancer Res 2004;64:7822-35.
36. Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005;167:1257-66.
37. Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, et al. Related to testes-specific vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Cancer Res 2006;66:4139-48.
38. Kowalczyk J, Domal-Kwiatkowska D, Mazurek U, Zembala M, Michalski B, Zembala M. Post translational modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy. Cell Mol Lett 2007;12:331-47.
39. Livak KJ, Schmittgen TJ. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;25:402-8.
40. Rentz TJ, Poobalarahi F, Bornstein P, Sage EH, Bradshaw AD. SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem 2007;282:22062-71.
41. Yang S-Z, Zhang L-M, Huang Y-L, Sun F-Y. Distribution of FLK-1 and FLT-1 receptors in neonatal and adult rat brains. Anat Rec Part A 2003;274:851-56.
42. De S, Chen J, Narizhneva NV, Heston W, Brainard J, Sage EH, Byzova TV. Molecular pathway for cancer metastasis to bone. J Biol Chem 2003;278:39044-50.
43. Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH. Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen 2001;9:522-30.
44. Yan M, Schneider J, Gear R, Lu F, LaDow K, Warshawsky D, Heffelfinger SC. Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies. Pathobiology 2004;71:253-60.
45. Kraemer M, Toumaire R, Dejong V, Montreau N, Briane D, Derbin C, Binetruy B. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors. Cell Growth Differ 1999;10:193-200.
46. Cody NAL, Ouellet V, Manderson EN, Quinn MCJ, Filali-Mouhim A, Tellis P, Zietarska M, Provencher DM, Mes-Masson A-M, Chevrette M, Tonin PN. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p. Oncogene 2007;26:618-32.
47. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, et al. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci USA 2006;103:16466-71.